Outrun Therapeutics Limited, Dundee
Outrun Therapeutics Limited is a private limited company. Situated at Errol Road, Invergowrie, Dundee DD2 5DA, this 4 years old enterprise was incorporated on 2019-11-26 and is officially classified as "other human health activities" (SIC: 86900).6 directors can be found in the company: Carolyn P. (appointed on 06 February 2024), Bauke A. (appointed on 27 November 2023), Anthony J. (appointed on 23 September 2022).
| About | |
|---|---|
| Name: Outrun Therapeutics Limited | |
| Number: SC648164 | |
| Incorporation date: 2019-11-26 | |
| End of financial year: 31 December |
| Address: |
Errol Road Invergowrie Dundee DD2 5DA |
| SIC code: |
86900 - Other human health activities |
Company staff
People with significant control
Mitsubishi Chemical Holdings Corporation
22 January 2022
| Address | 1-1-1 Marunouchi Palace Building, Chiyoda-Ku, 100-0005, Japan |
| Legal authority | Japan |
| Legal form | Public Limited Company |
| Country registered | Japan |
| Place registered | Japanese Commercial Registry |
| Registration number | 0104-01-059206 |
| Nature of control: |
25-50% voting rights 25-50% shares |
Merck Kgaa
22 January 2022
| Legal authority | Germany |
| Legal form | Public Limited Company |
| Country registered | Germany |
| Place registered | Unternehmensregister Deutschland |
| Registration number | Hrb 6164 |
| Nature of control: |
25-50% voting rights 25-50% shares |
Satpal V.
5 March 2021 - 22 January 2022
| Nature of control: |
25-50% voting rights 25-50% shares |
University Of Dundee (The)
26 November 2019 - 5 March 2021
| Legal authority | Uk Law |
| Legal form | Royal Charter Company |
| Country registered | United Kingdom |
| Place registered | United Kingdom |
| Registration number | Rc000649 |
| Nature of control: |
75,01-100% shares 75,01-100% voting rights |
Financial data
| Date of Accounts | 2020-12-31 | 2021-12-31 | 2022-12-31 |
| Current Assets | - | 453,798 | 1,702,459 |
| Fixed Assets | - | 171,018 | 203,913 |
| Total Assets Less Current Liabilities | - | 540,922 | 1,756,889 |
| Number Shares Allotted | 1 | - | - |
The due date for Outrun Therapeutics Limited confirmation statement filing is 2024-03-26. The latest one was submitted on 2023-03-12. The due date for the next statutory accounts filing is 30 September 2024. Previous accounts filing was submitted for the time period up until 31 December 2022.
4 persons of significant control are listed in the Companies House, namely: Mitsubishi Chemical Holdings Corporation owns 1/2 or less of shares, 1/2 or less of voting rights. The corporate PSC can be reached at Marunouchi Palace Building, 100-0005 Chiyoda-Ku. Merck Kgaa owns 1/2 or less of shares, 1/2 or less of voting rights. Satpal V. who owns 1/2 or less of shares, 1/2 or less of voting rights.
Company filing
Filter filings by category:
Accounts
Address
Capital
Confirmation statement
Incorporation
Officers
Persons with significant control
| Type | Free download | |
|---|---|---|
| AP01 |
On November 27, 2023 new director was appointed. filed on: 13th, December 2023 | officers |
Free Download
(2 pages)
|